India In-vitro Fertilization Market to Grow with a CAGR of 8.92% through 2029

Growing success rate of IVF technology and increasing cases of infertility is expected to drive the India In-vitro Fertilization Market growth in the forecast period, 2025-2029.

According to TechSci Research report, “India In-vitro Fertilization Market -Industry Size, Share, Trends, Competition Forecast & Opportunities, 2029”, the India In-vitro Fertilization Market stood at USD 845.07 Million in 2023 and is anticipated to grow with a CAGR of 8.92% in the forecast period, 2025-2029. Several factors are driving the growth of the in-vitro fertilization (IVF) market in India. The increasing incidence of infertility due to lifestyle changes, such as delayed childbearing and increasing stress levels, are contributing to the growth. Advancements in IVF technology, such as the introduction of time-lapse imaging and preimplantation genetic diagnosis, are also propelling the market.

Furthermore, government initiatives to promote medical tourism, combined with the cost-effectiveness of IVF procedures in India compared to other countries, are attracting patients from all over the world. The rise in disposable income and increased awareness about IVF among the general population are also significant factors.

Browse over XX market data Figures spread through XX Pages and an in-depth TOC on "India In-vitro Fertilization Market”

The Indian In-vitro Fertilization (IVF) market has witnessed an unprecedented growth in recent years, driven by the rising prevalence of infertility, advancements in technology, and growing awareness and acceptance of IVF treatments. Infertility, defined as the inability to conceive after a year of trying, affects approximately 10-14% of the Indian population, propelling the demand for effective treatments like IVF.

Technological advancements in the field, like the introduction of time-lapse imaging and preimplantation genetic testing, have significantly improved the success rates of IVF treatments and made it an increasingly popular choice for childless couples. Time-lapse imaging allows for continuous monitoring of the developing embryos without the need for removal from the incubator, reducing external disturbances and improving the chances of successful implantation. Preimplantation genetic testing enables the identification of genetic defects within embryos, ensuring that only healthy embryos are implanted, thus reducing the risk of genetic disorders and increasing the overall success rate of IVF cycles.

The importance of these advancements cannot be overstated, particularly in a society where the pressure to have a child can be overwhelming. Indian society places a high value on parenthood, and the inability to have children can lead to social stigma, making the promise of successful IVF treatments even more appealing.

Moreover, increased awareness and acceptance of IVF treatments have also played a significant role in the growth of the market. Various awareness campaigns have been launched to educate the public about infertility and the available treatment options. Additionally, celebrity endorsements and testimonials have helped destigmatize IVF, making it an increasingly accepted treatment method. However, despite the positive growth in the market, the high cost of IVF procedures and the lack of insurance coverage continue to be deterrents for many couples. Looking ahead, the Indian IVF market shows great promise. Ongoing advancements in technology will continue to enhance treatment outcomes, while growing awareness and acceptance will further expand the market. However, the challenge remains in making these treatments more accessible and affordable to the masses in order to truly unlock the potential of this market.

The India In-vitro Fertilization Market is segmented into technique, product, donor, infertility, embryo, end user, regional distribution, and company.

Based on technique, the Intracytoplasmic Sperm Injection (ICSI) IVF technique is projected to dominate the IVF market in India, owing to its higher success rate compared to Non-ICSI/Traditional IVF. This is particularly beneficial in cases of severe male infertility, where the precise and targeted approach of ICSI significantly enhances the chances of successful fertilization.

Moreover, the growing awareness about the benefits of ICSI IVF among patients and healthcare providers alike has led to an increased demand for this advanced technique. The remarkable success stories of couples who have achieved parenthood through ICSI IVF have further fueled the interest in this cutting-edge reproductive technology. With the increasing availability of ICSI IVF in modern healthcare facilities across India, more couples struggling with infertility are now able to access and benefit from this revolutionary treatment. Given these factors, it is anticipated that the dominance of ICSI IVF in the Indian market will continue to expand. As more individuals and healthcare professionals recognize the potential advantages it offers in the treatment of infertility, the prevalence of ICSI IVF is poised to grow, bringing hope and joy to countless families across the nation.

Based on region, the West India region is predominantly leading the Indian in-vitro fertilization (IVF) market due to a multitude of factors. Firstly, states in this region, especially Maharashtra and Gujarat, have a higher number of fertility clinics and hospitals, offering advanced and quality fertility treatments. These clinics and hospitals are equipped with state-of-the-art facilities and staffed by skilled medical professionals who specialize in reproductive medicine. The affluent economic status of the populace in this region allows for a higher spending capacity on treatments like IVF. This enables individuals and couples to access the latest advancements in assisted reproductive technology, such as preimplantation genetic testing and intracytoplasmic sperm injection, which can increase the chances of successful pregnancies.

Moreover, there is greater awareness and acceptance of IVF treatments in these areas, boosted by progressive societal norms and increased literacy rates. Educational campaigns and support groups have played a significant role in disseminating information about the benefits and success rates of IVF, thereby reducing the stigma associated with fertility treatments. Furthermore, the West India region benefits from a robust network of ancillary services related to IVF, including embryology laboratories, cryopreservation facilities, and fertility counseling centers. These additional services enhance the overall experience for patients, ensuring comprehensive care throughout their fertility journey. The presence of leading academic institutions and research centers in this region fosters innovation and collaboration among scientists, clinicians, and embryologists. This creates a conducive environment for groundbreaking research and the development of cutting-edge techniques in assisted reproductive technology. All these factors combined contribute to the dominance of the West India region in the Indian IVF market, making it a preferred destination for individuals seeking fertility treatments.

Major companies operating in India In-vitro Fertilization Market are:

• Merck India
• ORIGIO India Pvt Ltd.
• IMV India Pvt. Ltd.
• Thermo Fisher Scientific India Pvt. Ltd.
• Travancore Trade Links
• Cook Medical India
• Morpheus Life Sciences Pvt. Ltd.
• Max Healthcare Institute Limited
• Olympus Medical Systems India Pvt Ltd.
• FUJIFILM India Pvt Ltd.

Download Free Sample Report

Customers can also request for 10% free customization on this report.

“The future of the In-vitro Fertilization (IVF) market in India appears promising, driven by an increasing prevalence of infertility, advancements in technology, and a growing acceptance of IVF procedures. Trends suggest a progressive rise in the use of assisted reproductive technology due to a change in socio-cultural attitudes. However, factors such as expensive treatment procedures and lack of stringent regulatory framework may pose challenges to the growth of the market. Nonetheless, the rising middle-class population and their increasing disposable income are expected to provide ample opportunities for the expansion of the IVF market in India.,” said Mr. Karan Chechi, Research Director with TechSci Research, a research-based management consulting firm.

“India In-vitro Fertilization Market By Technique (ICSI IVF, Non-ICSI/ Traditional IVF), By Product (IVF Culture Media, ICSI Machine, IVF Incubators, Cryosystem, Others), By Donor (Fresh Non-donor, Frozen Non-donor, Fresh Donor, Frozen Donor), By Infertility (Male, Female), By Embryo (Fresh Embryo, Frozen-thawed Embryo), By End User (Fertility Clinics, Hospitals, Others), By Region, Competition, Forecast & Opportunities, 2019-2019F”, has evaluated the future growth potential of India In-vitro Fertilization Market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in India In-vitro Fertilization Market.

Contact

Techsci Research LLC

420 Lexington Avenue, Suite 300,

New York, United States- 10170

M: +13322586602

Email: [email protected]